LAUREN BARNETT: Open Payments
NPI 1104419878 · MONROE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 46 payments from 31 companies in 2025. Trend: 2023 $1,110 · 2024 $2,259 · 2025 $1,326
Food & beverage: $1,043Long term medical supply or device loan: $283
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $331 |
| Merck Sharp & Dohme LLC | 3 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| GENZYME CORPORATION | 2 | $57 |
| Geron Corporation | 2 | $52 |
| Aveo Pharmaceuticals, Inc. | 2 | $51 |
| PharmaEssentia USA Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| ARRAY BIOPHARMA INC | 2 | $42 |
| PFIZER INC. | 2 | $40 |
Products named: KISQALI, KEYTRUDA, LIBTAYO, RYTELO, FOTIVDA, BESREMI, BRAFTOVI, ZEPZELCA.
Industry payments across GA — which companies pay providers there.
